EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Retention of lysosomal acid sphingomyelinase protects from Niemann-Pick Disease

Cameron A Beard, Kyra N Hermanson, Justin M Snider, Aki Hara, Brandon K Dahl, Janet J Allopenna, Marilyn T Marron, Benjamin Newcomb, Benjamin E Low, Michael V Wiles, Russell W Jenkins, Lina M Obeid und 2 weitere

Neurobiology of Disease · 2025

DOI: 10.1016/j.nbd.2025.107147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurobiology of Disease, 2025. Verfasst von Cameron A Beard und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Nutritional Sciences and Wellness, University of Arizona, Tucson, AZ 85721, USA; College of Medicine Tucson, University of Arizona, Tucson,…. Hauptthemen laut MEDLINE: Sphingomyelin Phosphodiesterase, Niemann-Pick Diseases, Lysosomes. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NICHD NIH HHS, National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Niemann-Pick Disease (NPD) types A and B are lysosomal storage disorders resulting from dysfunction or loss of acid sphingomyelinase (aSMase), which hydrolyzes sphingomyelin (SM) to ceramide and phosphocholine. Patients with NPD-A develop severe neurologic and visceral pathology and rarely live beyond the age of 3 years, while patients with NPD-B typically live to adolescence/early adulthood without neurologic involvement. There are currently no therapies for NPD-A. SMPD1, the gene that encodes aSMase, gives rise to two distinct enzymes - lysosomal sphingomyelinase (L-SMase) and secretory sphingomyelinase (S-SMase), with the latter being associated with inflammation and chemokine amplification. This study sought to define the role of secretory-deficient aSMase variants in NPD. Human NPD fibroblasts transfected with wildtype or two aSMase variants demonstrated that serine residues at either position 507 or 508 in human aSMase retained L-SMase yet lacked S-SMase activity, basally and in response to inflammatory stimuli. We next generated a novel mouse model harboring the S505A variant (aSMaseS505A), corresponding to S507A in humans, in the endogenous Smpd1 gene. Mice expressing the S505A variant of aSMase retained L-SMase activity and tissue SM levels in the brain but lacked S-SMase activity in serum. ASMaseS505A mice were protected from NPD physiology and pathophysiology including accumulation of foam cells in the spleen, liver and cerebellum, as well as loss of Purkinje cells. Moreover, aSMase-/- mice demonstrated significantly decreased locomotor control and this was prevented in aSMaseS505A mice. Together, these studies suggest a retention of L-SMase may serve to pave the way for ERT in NPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sphingomyelin PhosphodiesteraseNiemann-Pick DiseasesLysosomesAnimalsHumansMiceMice, KnockoutMaleMice, Inbred C57BLDisease Models, AnimalFibroblastsNiemann-Pick Disease, Type A

Stichwörter der Autor:innen

Acid sphingomyelinaseCeramideLysosomal storage disorderNieman-pick diseaseSphingomyelin

Substanzen

Sphingomyelin PhosphodiesteraseSMPD1 protein, humanASMase, mouse

Autor:innen und Institutionen

  • School of Nutritional Sciences and Wellness, University of Arizona, Tucson, AZ 85721, USA; College of Medicine Tucson, University of Arizona, Tucson, AZ 85721, USA.
  • Department of Physiology, University of Arizona, Tucson, AZ 85721, USA.
  • School of Nutritional Sciences and Wellness, University of Arizona, Tucson, AZ 85721, USA; University of Arizona Cancer Center, University of Arizona, Tucson, AZ 85721, USA.
  • School of Nutritional Sciences and Wellness, University of Arizona, Tucson, AZ 85721, USA.
  • Department of Medicine and Stony Brook Cancer Center, Stony Brook, NY 11794, USA.
  • Technology Evaluation and Development, The Jackson Laboratory, Bar Harbor, ME, USA; Genetic Resource Science, The Jackson Laboratory, Bar Harbor, ME, USA.

Förderung

  • NCI NIH HHS
  • NICHD NIH HHS
  • National Institute of Child Health and Human Development
  • National Institutes of Health National Cancer Institute
  • National Institutes of Health

Zitieren

APA

Beard, C. A., Hermanson, K. N., Snider, J. M., Hara, A., Dahl, B. K., Allopenna, J. J., Marron, M. T., Newcomb, B., Low, B. E., Wiles, M. V., Jenkins, R. W., Obeid, L. M., Hannun, Y. A., & Snider, A. J. (2025). Retention of lysosomal acid sphingomyelinase protects from Niemann-Pick Disease. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2025.107147

Vancouver

Beard CA, Hermanson KN, Snider JM, Hara A, Dahl BK, Allopenna JJ, et al. Retention of lysosomal acid sphingomyelinase protects from Niemann-Pick Disease. Neurobiology of Disease. 2025. doi:10.1016/j.nbd.2025.107147

BibTeX
@article{Beard2025,
  author = {Beard, Cameron A and Hermanson, Kyra N and Snider, Justin M and Hara, Aki and Dahl, Brandon K and Allopenna, Janet J and Marron, Marilyn T and Newcomb, Benjamin and Low, Benjamin E and Wiles, Michael V and Jenkins, Russell W and Obeid, Lina M and Hannun, Yusuf A and Snider, Ashley J},
  title = {Retention of lysosomal acid sphingomyelinase protects from Niemann-Pick Disease},
  journal = {Neurobiology of Disease},
  year = {2025},
  doi = {10.1016/j.nbd.2025.107147}
}
Kostenlos starten →